Used in pharmaceutical research as a key intermediate in the synthesis of potent neurokinin receptor antagonists. Shows promise in the development of treatments for neurological disorders such as depression, anxiety, and migraine due to its ability to cross the blood-brain barrier and modulate central nervous system activity. Its trifluoroacetyl group enhances metabolic stability and binding affinity, making it valuable in optimizing drug candidates for improved efficacy and pharmacokinetics.